Literature DB >> 15957164

High constant incidence rates of second cutaneous melanomas.

Fabio Levi1, Lalao Randimbison, Van-Cong Te, Carlo La Vecchia.   

Abstract

The incidence of most epithelial cancers rises with a power of age. However, second breast cancers have a high constant incidence independent of age. The skin is one of the few other sites allowing examination of age incidence curves of second neoplasms of the same organ. We considered the risk of second primary cutaneous malignant melanoma (CMM) in a population-based series of 3,439 first CMM registered and followed-up between 1974 and 2003 in the Swiss Cantons of Vaud and Neuchâtel (about 786,000 inhabitants). A total of 43 cases of second CMM were observed vs. 9.3 expected, corresponding to a standardized incidence ratio (SIR) of 4.6. The SIR was 8.5 under age 50, 5.7 at age 50-59 and 3.5 at age 60 or over. At 20 years, the cumulative risk of second CMM was 5%. Age-specific incidence rates of second primary CMM did not vary across age groups 30-39 through 80+, ranging between 1 and 2.5 per 1,000 person-years. Thus, the risk of CMM is substantially increased in subjects diagnosed with a CMM, and the relative risk is greater at younger age and declines with advancing age. The high constant incidence curve of second CMM is compatible with the occurrence of a single mutational event in a population of susceptible individuals. Copyright 2005 Wiley-Liss, Inc

Entities:  

Mesh:

Year:  2005        PMID: 15957164     DOI: 10.1002/ijc.21262

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Ambient UV, personal sun exposure and risk of multiple primary melanomas.

Authors:  Anne Kricker; Bruce K Armstrong; Chris Goumas; Melisa Litchfield; Colin B Begg; Amanda J Hummer; Loraine D Marrett; Beth Theis; Robert C Millikan; Nancy Thomas; Hoda Anton Culver; Richard P Gallagher; Terence Dwyer; Timothy R Rebbeck; Peter A Kanetsky; Klaus Busam; Lynn From; Urvi Mujumdar; Roberto Zanetti; Marianne Berwick
Journal:  Cancer Causes Control       Date:  2007-01-06       Impact factor: 2.506

Review 2.  Update in genetic susceptibility in melanoma.

Authors:  Miriam Potrony; Celia Badenas; Paula Aguilera; Joan Anton Puig-Butille; Cristina Carrera; Josep Malvehy; Susana Puig
Journal:  Ann Transl Med       Date:  2015-09

3.  Second Primary Melanoma: Risk Factors, Histopathologic Features, Survival, and Implications for Follow-Up.

Authors:  Maris S Jones; Hitoe Torisu-Itakura; Devin C Flaherty; Hans F Schoellhammer; Jihey Lee; Myung-Shim Sim; Mark B Faries
Journal:  Am Surg       Date:  2016-10       Impact factor: 0.688

4.  Nevi, family history, and fair skin increase the risk of second primary melanoma.

Authors:  Victor Siskind; Maria Celia B Hughes; Jane M Palmer; Judith M Symmons; Joanne F Aitken; Nicholas G Martin; Nicholas K Hayward; David C Whiteman
Journal:  J Invest Dermatol       Date:  2010-10-14       Impact factor: 8.551

5.  Metabolomic identification of diagnostic serum-based biomarkers for advanced stage melanoma.

Authors:  A W L Bayci; D A Baker; A E Somerset; O Turkoglu; Z Hothem; R E Callahan; R Mandal; B Han; T Bjorndahl; D Wishart; R Bahado-Singh; S F Graham; R Keidan
Journal:  Metabolomics       Date:  2018-08-03       Impact factor: 4.290

Review 6.  Variability in melanoma post-treatment surveillance practices by country and physician specialty: a systematic review.

Authors:  Kate D Cromwell; Merrick I Ross; Yan Xing; Jeffrey E Gershenwald; Richard E Royal; Anthony Lucci; Jeffrey E Lee; Janice N Cormier
Journal:  Melanoma Res       Date:  2012-10       Impact factor: 3.599

Review 7.  Magnetic nanoparticles in theranostics of malignant melanoma.

Authors:  Maxim Shevtsov; Susanne Kaesler; Christian Posch; Gabriele Multhoff; Tilo Biedermann
Journal:  EJNMMI Res       Date:  2021-12-14       Impact factor: 3.138

8.  Canadian Melanoma Conference Recommendations on High-Risk Melanoma Surveillance: A Report from the 14th Annual Canadian Melanoma Conference; Banff, Alberta; 20-22 February 2020.

Authors:  Christina W Lee; J Gregory McKinnon; Noelle Davis
Journal:  Curr Oncol       Date:  2021-05-27       Impact factor: 3.677

Review 9.  Melanoma epidemiology, biology and prognosis.

Authors:  Z Ali; N Yousaf; J Larkin
Journal:  EJC Suppl       Date:  2013-09

10.  CDKN2A/CDK4 Status in Greek Patients with Familial Melanoma and Association with Clinico-epidemiological Parameters.

Authors:  Fani Karagianni; Ching-Ni Njauw; Katerina P Kypreou; Aravela Stergiopoulou; Michaela Plaka; Dorothea Polydorou; Vasiliki Chasapi; Leontios Pappas; Ioannis A Stratigos; Gregory Champsas; Peter Panagiotou; Helen Gogas; Evangelos Evangelou; Hensin Tsao; Alexander J Stratigos; Irene Stefanaki
Journal:  Acta Derm Venereol       Date:  2018-10-10       Impact factor: 4.437

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.